Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
The article describes prevalence and risk factors of cardiovascular in patients with cancer. The problems of anthracycline-induced cardiotoxicity, the deleterious effects of doxorubicin on the heart, as well as the cardioprotective effects of beta-blockers and agents acting on the renin-angiotensin-...
Main Authors: | I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, I. O. Kudaibergenova, F. A. Yusupov, Zh. A. Murkamilova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2021-03-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2583 |
Similar Items
-
Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01) -
Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01) -
The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01) -
ANTHRACYCLINE CARDIOTOXICITY MODELING USING INTRACELLULAR ATP LEVELS IN NEONATAL RAT HEART CELL CULTURES (CHEMOTHERAPY, DOXORUBICIN, MYOCYTES)
by: Bozak, Karen Aline, 1960-
Published: (1986) -
LEVELS OF INTERLEUKINS AND MELATONIN IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-11-01)